In 2024, Pfizer completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Pfizer has also provided a category-level breakdown for 10 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021-2019 |
|---|---|---|---|---|
Total Scope 1 | 613,218a | 617,404a | 644,565a | |
Total Scope 2 | ||||
Market-Based | 465,128a | 490,632a | 483,281a | |
Location-Based | 450,093a | 461,084a | 498,822a | |
Total Scope 3 | 3,555,207a | 4,303,654a | 9,377,729a | |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 9.6377a | 10.5546a | 6.4244a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2024, the total operational greenhouse gas (GHG) emissions of Pfizer amounted to 1,063,311 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Pfizer decreased by 1.41%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a
In 2024, the total Scope 1 emissions of Pfizer were 613,218 metric tons of CO₂ equivalent (tCO₂e).a
Since 2019, Pfizer's Scope 1 emissions have decreased by 11.78%, reflecting a declining long-term trend in Scope 1 emissions over time.a
Compared to the previous year (2023), Pfizer's Scope 1 emissions remained relatively stable, indicating that Pfizer's emissions have plateaued with no significant change in its operational footprint.a
In 2024, Pfizer reported Scope 2 greenhouse gas (GHG) emissions of 465,128 tCO₂e using the market-based method and 450,093 tCO₂e using the location-based method.a
Since 2019, Pfizer's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have decreased by 19.48%, reflecting a declining long-term trend in Scope 2 emissions over time.a
Compared to the previous year (2023), Pfizer's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Pfizer's emissions have plateaued with no significant change in its energy consumption footprint.a
In 2024, Pfizer reported its Scope 2 emissions using the market-based method and using the location-based method.a
In 2024, Pfizer reported 3,555,207 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2024 disclosure of Pfizer includes a breakdown across 10 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
In 2024, Pfizer reported total Scope 3 emissions of 3,555,207 metric tons of CO₂ equivalent (tCO₂e).a
Approximately 99.79% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0.21% came from downstream activities like product use, distribution, and end-of-life treatment.a
Since 2019, Pfizer's Scope 3 emissions have increased by 14.05%, reflecting a rising long-term trend in Scope 3 emissions over time.a
Compared to the previous year (2023), Pfizer's Scope 3 emissions decreased by 17.39%, highlighting the company's efforts to lower indirect emissions from its value chain.a
In 2024, Pfizer reported emissions for 10 out of the 15 Scope 3 categories defined by the GHG Protocol.a
This reflects a high level of granularity and transparency in the company's emissions reporting.
In 2024, the largest contributors to Pfizer's Scope 3 emissions were:a
In 2024, Pfizer reported Scope 1 greenhouse gas (GHG) emissions of 613,218 tCO₂e and total revenues of USD 63,627 millions. This translates into an emissions intensity of 9.64 tCO₂e per millions USD.a
In 2024, Pfizer reported a Scope 1 emissions intensity of 9.64 tCO₂e per millions USD. Compared to the peer group median of 5.15, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a
In 2024, Pfizer ranked 19 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
Pfizer is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a
In 2024, Pfizer reported a total carbon footprint of 4,618,518 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 14.19% decrease compared to 2023, indicating progress in reducing its overall greenhouse gas output.a
The largest contributor to Pfizer's total carbon footprint was Scope 3 emissions, accounting for 76.98% of the company's total carbon footprint, followed by Scope 1 emissions at 13.28%.a